Bluejay Diagnostics (BJDX) Change in Inventory (2020 - 2022)

Bluejay Diagnostics (BJDX) reported Change in Inventory of -$221924.0 for Q2 2022, down 124.85% sequentially from $893174.0 in Q1 2022.

Bluejay Diagnostics (BJDX) Change in Inventory (2020 - 2022) Analysis & Trends

Bluejay Diagnostics (BJDX) has 2 years of Change in Inventory data on file, last reported at -$221924.0 in Q2 2022.

For the quarter ending Q2 2022, Change in Inventory changed N/A year-over-year to -$221924.0; the trailing twelve-month figure through Jun 2022 stood at $671250.0 (changed N/A YoY), and the FY2021 full-year result was -$84762.0, down 118.76% from the prior year.
Change in Inventory retreated to -$221924.0 in Q2 2022, from $893174.0 in the prior quarter.
In the past five years, Change in Inventory ranged from a high of $893174.0 in Q1 2022 to a low of -$221924.0 in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Inventory (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	420.00 Mn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	127.00 Mn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	-399.00 Mn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	177.00 Mn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	1.60 Mn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	65.20 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	-264.59 Mn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	171.00 Mn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	-
10	Bluejay Diagnostics	2,754.24	2,754.24	-	-

Download Data